Research and Markets: Rabies Pipeline Insights 2015 - Pipeline Products Coverage Based on Various Stages of Development from NDA Filings to Discovery

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/wjrvgk/rabiespipeline) has announced the addition of the "Rabies-Pipeline Insights" report to their offering.

Rabies- Pipeline Insights provides the in-depth analysis of the pipeline assets across the Rabies. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Rabies Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

Rabies- Pipeline Insights Report covers the Rabies pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Rabies related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Rabies.

Scope

  • The report provides a Rabies Landscape across the globe.
  • The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information.
  • Coverage of the Rabies pipeline on the basis of target, MOA, route of administration, technology involved and molecule type.
  • The report reviews key players involved in the therapeutics development for Rabies and also provide company profiling.
  • Pipeline products coverage based on various stages of development from NDA filings to discovery.
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type.

Key Topics Covered:

  • Rabies Overview
  • Rabies Pipeline Therapeutics
  • Rabies Therapeutics under Development by Companies
  • Rabies Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Rabies Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Rabies Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Rabies Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Rabies - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Rabies - Discontinued Products
  • Rabies - Dormant Products
  • Companies Involved in Therapeutics Development for Rabies

For more information visit http://www.researchandmarkets.com/research/wjrvgk/rabiespipeline

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals